Reuters logo
BRIEF-Asterias Biotherapeutics announces data monitoring committee
2017年4月25日 / 中午11点36分 / 7 个月前

BRIEF-Asterias Biotherapeutics announces data monitoring committee

April 25 (Reuters) - Asterias Biotherapeutics Inc

* Asterias Biotherapeutics announces data monitoring committee unanimously recommends continuation of scistar phase 1/2A clinical trial of AST-OPC1 for cervical spinal cord injury

* Expects to report additional efficacy and safety data for Cohort 2, and for currently-enrolling cohorts 3 and 4, later this year Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below